Boston Scientific: Beaten Down But Not Broken - A Mid-Term Value Trade
<p>Boston Scientific (BSX) has tumbled from a $109.50 52-week high to trade near $44.27 today, punished by guidance cuts and procedure mix headwinds. Fundamentals still show scale, cash generation and manageable leverage, while recent positive trial data and a strategic push into TAVR create asymmetric upside. This is a tactical, mid-term trade loo…